## [A global pharma leader de-risks a multi-year CIAM migration](/content/case-study/ciam-migration-consulting-pharma-case-study/index.html)

How a Fortune Global 500 pharmaceutical company validated its identity and consent architecture before execution, with Next Reason, Akamai’s Customer